MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.3B
This Quarter Return
+8.9%
1 Year Return
+46.22%
3 Year Return
+108.24%
5 Year Return
–
10 Year Return
–
AUM
$14.6B
AUM Growth
+$14.6B
(-17%)
Cap. Flow
-$4.02B
Cap. Flow
% of AUM
-27.6%
Top 10 Holdings %
Top 10 Hldgs %
20.74%
Holding
1,653
New
314
Increased
216
Reduced
349
Closed
768
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$213M |
| 2 |
Medtronic
MDT
|
$130M |
| 3 |
Charter Communications
CHTR
|
$105M |
| 4 |
Merck
MRK
|
$99.9M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
$96.5M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$230M |
| 2 |
Baidu
BIDU
|
$120M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$112M |
| 4 |
Constellation Brands
STZ
|
$111M |
| 5 |
Abbott
ABT
|
$110M |
Sector Composition
| 1 | Healthcare | 31.1% |
| 2 | Technology | 16.39% |
| 3 | Industrials | 11.22% |
| 4 | Consumer Discretionary | 9.86% |
| 5 | Financials | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Fortive
FTV
$15.9B
| $51.3M | 0.35% |
609,477
-86,003
| -12% | -$7.24M |
|
77
Broadridge
BR
$29.1B
| $50.8M | 0.35% |
+384,864
| New | +$50.8M |
|
78
Dollar Tree
DLTR
$21.4B
| $50.7M | 0.35% |
621,135
+417,762
| +205% | +$34.1M |
|
79
Wells Fargo
WFC
$257B
| $50.5M | 0.35% |
960,635
+124,922
| +15% | +$6.57M |
|
80
Ascendis Pharma
ASND
$12B
| $49.8M | 0.34% |
703,087
+63,540
| +10% | +$4.5M |
|
81
Becton Dickinson
BDX
$53.6B
| $49.7M | 0.34% |
+190,568
| New | +$49.7M |
|
82
Lockheed Martin
LMT
$105B
| $49.6M | 0.34% |
143,458
+77,696
| +118% | +$26.9M |
|
83
Cognizant
CTSH
$35B
| $48.9M | 0.34% |
634,067
-4,470
| -0.7% | -$345K |
|
84
ADT
ADT
$7.04B
| $48.5M | 0.33% |
5,168,705
+728,797
| +16% | +$6.84M |
|
85
Palo Alto Networks
PANW
$128B
| $47.4M | 0.33% |
210,516
+37,558
| +22% | +$8.46M |
|
86
Citigroup
C
$173B
| $45.5M | 0.31% |
634,273
+97,326
| +18% | +$6.98M |
|
87
SBA Communications
SBAC
$21.4B
| $43.8M | 0.3% |
272,905
-16,963
| -6% | -$2.72M |
|
88
Equinix
EQIX
$74.3B
| $43.3M | 0.3% |
99,954
| – | – |
|
89
Cooper Companies
COO
$13.2B
| $40.2M | 0.28% |
144,900
+130,043
| +875% | +$36M |
|
90
Keysight
KEYS
$28.5B
| $38.9M | 0.27% |
586,953
-553,906
| -49% | -$36.7M |
|
91
Intuitive Surgical
ISRG
$158B
| $38.9M | 0.27% |
67,772
+21,062
| +45% | +$12.1M |
|
|
NBIS
92
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.9B
| $38.6M | 0.27% |
1,174,459
-405,217
| -26% | -$13.3M |
|
93
Burlington
BURL
$18.5B
| $38.6M | 0.27% |
237,024
-174,449
| -42% | -$28.4M |
|
94
Mastercard
MA
$535B
| $37.3M | 0.26% |
167,713
+87,311
| +109% | +$19.4M |
|
95
CF Industries
CF
$13.9B
| $37.3M | 0.26% |
+685,532
| New | +$37.3M |
|
96
Texas Instruments
TXN
$177B
| $37.2M | 0.26% |
+346,488
| New | +$37.2M |
|
97
Amicus Therapeutics
FOLD
$2.39B
| $37.1M | 0.25% |
3,068,679
+2,863,872
| +1,398% | +$34.6M |
|
98
Royal Caribbean
RCL
$96.4B
| $36.9M | 0.25% |
284,038
+91,771
| +48% | +$11.9M |
|
|
CA
99
DELISTED
CA, Inc.
CA
| $36.8M | 0.25% |
+834,405
| New | +$36.8M |
|
100
Novartis
NVS
$248B
| $36.7M | 0.25% |
425,703
-387,439
| -48% | -$33.4M |
|